Sivik Global Healthcare LLC Has $4.83 Million Stake in Encompass Health Co. (NYSE:EHC)

Sivik Global Healthcare LLC reduced its position in Encompass Health Co. (NYSE:EHC - Free Report) by 9.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 50,000 shares of the company's stock after selling 5,000 shares during the quarter. Encompass Health comprises about 2.0% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 24th biggest position. Sivik Global Healthcare LLC's holdings in Encompass Health were worth $4,832,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in EHC. UMB Bank n.a. increased its stake in shares of Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company's stock worth $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after acquiring an additional 140 shares during the period. Oakworth Capital Inc. bought a new stake in shares of Encompass Health during the second quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. boosted its position in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after acquiring an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Encompass Health in the 2nd quarter valued at about $58,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Barclays boosted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a report on Tuesday, October 29th. KeyCorp upped their price objective on Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. UBS Group lifted their target price on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. Stephens reaffirmed an "overweight" rating and issued a $105.00 price target on shares of Encompass Health in a report on Tuesday, August 6th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $107.11.

Encompass Health Stock Down 1.5 %

EHC stock traded down $1.50 during mid-day trading on Thursday, hitting $101.19. The stock had a trading volume of 540,560 shares, compared to its average volume of 640,558. Encompass Health Co. has a 1-year low of $63.59 and a 1-year high of $104.55. The company has a fifty day moving average of $96.08 and a 200 day moving average of $90.07. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $10.19 billion, a price-to-earnings ratio of 24.80, a PEG ratio of 1.36 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the business posted $0.86 earnings per share. The business's quarterly revenue was up 11.9% on a year-over-year basis. On average, equities analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health's payout ratio is presently 16.43%.

Encompass Health declared that its board has approved a stock buyback plan on Wednesday, July 24th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 5.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board of directors believes its shares are undervalued.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.